At first, our analysis revealed a consistent picture of high MDK expression in grade II, III, and IV gliomas compared to healthy brain tissues, with its expression increasing proportionally to the tumor grade (Fig. 1a). The gene discussed is MDK; the disease is central nervous system cancer.